Mpox illnesses, including severe infections, continue to occur across the United States. The Strategic National Stockpile remains focused on rapidly deploying mpox vaccines and therapeutics to the most affected communities and mitigating the spread of the disease while maintaining a focus on fair and equitable distribution of the product.
NOTE: On November 28, 2022, The World Health Organization announced the name “mpox” is to replace what was previously referred to as “monkeypox.” This site has been updated to reflect this change, while some material created prior to the change may still reflect the old name.
Related Resources:
Contact Us
For further questions or information about the Strategic National Stockpile, please email us at
sns.ops@cdc.gov.
